Thursday, September 09, 2004

Martek Comments on FDA Announcement of Cardiovascular Qualified Health Claim for DHA
"Martek Comments on FDA Announcement of Cardiovascular Qualified Health Claim for DHA
Thursday September 9, 2:42 pm ET
"COLUMBIA, Md., Sept. 9 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq:MATK - News) commented today on yesterday's FDA announcement allowing conventional foods and dietary supplements containing docosahexaenoic acid (DHA) to make a qualified health claim for reduced risk of coronary heart disease on their product packaging. The claim was, in part, a result of Martek's petition to the FDA in November of 2003. A qualified health claim must be supported by credible scientific evidence. Upon review of this scientific evidence, the FDA concluded that supportive but not conclusive research shows that consumption of DHA and eicosapentaenoic acid (EPA) may reduce the risk of coronary heart disease...."

Tuesday, September 07, 2004

Herald.com | 09/07/2004 | Toddlers often overcome allergy to milk
Posted on Tue, Sep. 07, 2004
BY HOWARD COHEN
hcohen@herald.com
"The slogan ''Milk, it does a body good'' doesn't apply to everyone. At 1 month old, Grace Fleitas' baby Amanda began exhibiting the classic signs of a milk allergy: irritability, bloody stools, diarrhea. After initially being breast fed, Amanda was being fed infant formula. ''She was really cranky, always crying,'' the Hialeah mother said. Fleitas, who never suffered from a milk allergy, tried formulas for colicky babies. When that didn't help, she took Amanda to Dr. Robert E. Kramer, an assistant professor of pediatrics at the University of Miami's Pediatric Gastroenterology division. Kramer put Amanda on EleCare, an amino-based infant pharmaceutical formula. After about six months, Amanda, now 18 months, can tolerate milk...."
KV Pharmaceutical Company Launches PrimaCare(R)ONE - First Prenatal Containing Essential Fatty Acids to Offer One Dose Convenience
Tuesday September 7, 8:07 am ET
Launch of PrimaCare(R)ONE Expands Ther-Rx's Continuum of Care for Women and Strengthens Leadership Position in Prescription Prenatals
"ST. LOUIS, Sept. 7 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) announced today that its Ther-Rx Corporation branded pharmaceutical subsidiary has launched PrimaCare®ONE. PrimaCare®ONE is a proprietary line extension to Ther-Rx's PrimaCare® nutritional product, one of the fastest growing prescription prenatal products in the branded segment with 9.3% market share....PrimaCare®ONE is formulated to provide both prenatal and postnatal nutritional support for mothers and babies, and ongoing nutritional support for women throughout their childbearing years with the convenience of one- dose-per-day dosage form. The product further extends Ther-Rx's leadership in marketing innovative branded pharmaceuticals to women in their childbearing years as part of its PreCare® family prescription nutritional product line...."

Wednesday, September 01, 2004

Some Bus Drivers Ban Breastfeeding, Protesters Allege
LATimes.com
LOS ANGELES
August 31, 2004
"A group of protesters accused Metropolitan Transportation Authority drivers of breaking a state law that allows women to breastfeed in public and picketed Tuesday outside its downtown Los Angeles headquarters. MTA officials apologized for drivers who have asked women to stop breastfeeding, but said they have no policy that bans breastfeeding on buses or trains...."